medigraphic.com
Instituto Nacional de Salud Pública

2014, Number 6

<< Back Next >>

salud publica mex 2014; 56 (6)

Seroprevalencia y detección de infección primaria por citomegalovirus mediante prueba de avidez IgG en el primer trimestre de embarazo

González-García CL, Reyes-Méndez MA, Ortega-Pierres LE, Rodríguez-Sánchez AP, Sandoval-Guido V, Sereno-Coló JA

Language: Spanish
References: 22
Page: 619-624
PDF size: 219.80 Kb.


ABSTRACT

Objective. To determine the seroprevalence and detection of primary infection by cytomegalovirus (CMV) with immunoglobulin G (IgG) avidity test during the first quarter of pregnancy in the General Hospital in Morelia, Michoacan. Materials and methods. A total of 177 patients were studied employing a modified Elisa test using a chemiluminescent microparticle immunoassay (CMIA) for the detection of CMV antibodies (IgG and immunoglobulin M [IgM]), and IgG avidity. Results. 90.4% were positive for IgG, and of these, 2.3% were also reactive for IgM, and in this group the IgG avidity test reported low avidity for 1.1% and higher avidity in the same percentage. 9.6% were seronegative. Conclusions. Similarity was found with published studies in Mexico. Health professionals should know the clinical algorithms for diagnosis and proper management of CMV infection using the IgG avidity test.


REFERENCES

  1. Gomilla A, Rivas N, López EL. Infección congénita por citomegalovirus. An Pediatr (Barc) 2008;68:311-315.

  2. García N, García L, Iglesias E, Ortiz L. Citomegalovirus y embarazo. Ginecología y Obstetricia Clínica 2004;3:156-169.

  3. Marín MA, Fernández M, González MI, Saavedra J, Barajas V, Rojo P, Ramos JT. Infección congénita por citomegalovirus en hijos de madres infectadas por el VIH. An Pediatr (Barc) 2005;62:38-42.

  4. Baquero F. Citomegalovirus congénito: ¿Es necesario un cribado serológico? Enferm Infecc Microbiol Clin 2010;28:363-369.

  5. Baquero F. Documento de consenso de la Sociedad Española de Infectología Pediátrica sobre el diagnóstico y tratamiento de la infección congénita por citomegalovirus. An Pediatr 2009;71:535-547.

  6. Ahued JR, Fernández C, Bailón R. Ginecología y obstetricia aplicadas. 2ª Ed. México: Manual Moderno, 2003:455-456.

  7. Nigro G, Adler SP. Cytomegalovirus infecttions during pregnancy. Curr Opin Obstet Gynecol 2011;23:123-128.

  8. Munro SC, Hall B, Whybin LR, Leader L, Robertson P, Maine GT, Rawlinson WD. Diagnosis of and screening for cytomegalovirus infection in pregnant women. J Clin Microbiol 2005;43:4713-4718.

  9. Hedman K, Lappalainen M, Söderlund M, Hedman L. Avidity of IgG in serodiagnosis of infectious diseases. Rev Med Microbiol 1993;4:123-129.

  10. Harlow E, Lane D. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory. Nueva York: Cold Spring Harbor, 1988:23-52.

  11. Bodeus M, Feyder S, Goubau P. Avidity of IgG antibodies distinguishes primary from non-primary cytomegalovirus infection in pregnant women. Clin Diagn Virol 1998;9:9-16.

  12. Grangeot L, Mayaux MJ, Lebon P, Freymuth F, Eugene G, Stricker R, Dussaix E. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J Infect Dis 1997;175:944-946.

  13. Kanengisser B, Hazan Y, Pines G, Appelman Z. High cytomegalovirus IgG avidity is a reliable indicator of past infection in patients with positive IgM detected during the first trimester of pregnancy. J Perinat Med 2009;37:15-18.

  14. Lagrou K, Bodeus M, Van Ranst M, Goubau P. Evaluation of the new Architect Cytomegalovirus Immunoglobulin M (IgM), IgG and IgG avidity assays. J Clin Microb 2009;47:1695-1699.

  15. Malinger G, Lev D, Lerman-Sagie T. Imaging of fetal cytomegalovirus infection. Fetal Diagn Ther 2011;29:117-126.

  16. Echániz G, Tamayo E, Cruz A, Rangel H, Hernández P, Gatica R, Calderón-Jaimes E. Prevalence of antibodies against cytomegalovirus in women of reproductive age. Salud Publica Mex 1993;35:20-26.

  17. Polanco G, Puerto F, Puerto M, González M, Albertos N, Baeza M. Prevalencia e incidencia de infección por citomegalovirus en mujeres embarazadas del estado de Yucatán, México. Rev Biomed 1996:7:127-131.

  18. Bonalumi S, Trapanese A, Santamaria A, D’Emidio L, Mobili L. Cytomegalovirus infection in pregnancy; review of the literatura. J Prenat Med 2011;5:1-8.

  19. Alarcón A, Baquero F. Revisión y recomendaciones sobre la prevención, diagnóstico y tratamiento de la infección posnatal por citomegalovirus. An Pediatr (Barc) 2011;74:52.e1-52.e13.

  20. Fowler FB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. The outcome of congenital cytomegalovirus in relation to maternal antibody status. N Engl J Med 1992;326:663-667.

  21. García I, Espinosa M, García JA, Diemon JB. Prevención, diagnóstico y tratamiento de la infección por Citomegalovirus en la edad pediátrica [documento en internet]. México: IMSS, 2013 [consultado el 22 de mayo de 2013]. Disponible en: http://www.imss.gob.mx/profesionales/guiasclinicas/Pages/guias.aspx

  22. Alder SP. Screening for citomegalovirus during pregnacy. Infect Dis Obstet Gynecol 2011;2011:1-9.




2020     |     www.medigraphic.com